Showing results (121-130 of 583) with videos related to
Sort By:
Pageof 59
Bioorganic & Medicinal Chemistry|January 8, 2011
17β-HSD2 inhibitors for the treatment of osteoporosis: Identification of a promising scaffoldMarie Wetzel, Sandrine Marchais-Oberwinkler, Rolf W HartmannJournal of Enzyme Inhibition|January 1, 1996
Novel 19-(cyclopropylamino)-androst-4-en-3,17-dione: a mechanism-based inhibitor of aromataseV C Njar, J Düerkop, R W HartmannJournal of Pharmaceutical and Biomedical Analysis|September 5, 2013
Development and validation of a UHPLC-MS/MS procedure for quantification of the Pseudomonas Quinolone Signal in bacterial culture after acetylation for characterization of new quorum sensing inhibitorsChristine K Maurer, Anke Steinbach, Rolf W HartmannJournal of Neurology|August 1, 1986
Correlation between protein data in normal lumbar CSF and morphological findings of choroid plexus epithelium: a biochemical corroboration of barrier transport via tight junction poresH Kluge, W Hartmann, B Mertins, et al.Journal of Enzyme Inhibition|January 1, 1995
Evaluation of 6,7-aziridinyl steroids and related compounds as inhibitors of aromatase (P-450arom)V C Njar, G Grün, R W HartmannMolecules (Basel, Switzerland)|April 18, 2013
Synthesis and biological evaluation of thieno[3,2-d]- pyrimidinones, thieno[3,2-d]pyrimidines and quinazolinones: conformationally restricted 17b-hydroxysteroid dehydrogenase type 2 (17b-HSD2) inhibitorsEnrico Perspicace, Sandrine Marchais-Oberwinkler, Rolf W HartmannThe Journal of Steroid Biochemistry and Molecular Biology|February 17, 2001
Development of a simple and rapid assay for the evaluation of inhibitors of human 17alpha-hydroxylase-C(17,20)-lyase (P450cl7) by coexpression of P450cl7 with NADPH-cytochrome-P450-reductase in Escherichia coliP B Ehmer, J Jose, R W HartmannEuropean Journal of Medicinal Chemistry|May 17, 2003
Discovery of selective CYP11B2 (aldosterone synthase) inhibitors for the therapy of congestive heart failure and myocardial fibrosisRolf W Hartmann, Ursula Müller, Peter B EhmerJournal of Cancer Research and Clinical Oncology|January 1, 1982
3,4-bis(3'-hydroxyphenyl)hexane--a new mammary tumor-inhibiting compound. Studies on the mechanism of action on the DMBA-induced, hormone-dependent mammary tumor of the ratR W Hartmann, H Schönenberger, K H WrobelJournal of Enzyme Inhibition and Medicinal Chemistry|December 30, 2006
A fission yeast-based test system for the determination of IC50 values of anti-prostate tumor drugs acting on CYP21Călin-Aurel Drăgan, Rolf W Hartmann, Matthias BureikPageof 59